Assessment of in vitro impact of low molecular weight heparin on expression of heparanase and heparin binding growth factors in the endometrium of women with impaired reproduction

被引:0
|
作者
Wirstlein, Przemyslaw [1 ]
Mikolajczyk, Mateusz [1 ]
Skrzypczak, Jana [1 ]
机构
[1] Uniwersytet Med K Marcinkowskiego Poznaniu, Katedra Ginekol Poloznictwa & Onkol Ginekol, Klin Rozrodczosci, PL-60535 Poznan, Poland
关键词
heparin; heparanase; heparin binding growth factors; endometrium; impaired reproduction; T-CELL ADHESION; SULFATE PROTEOGLYCANS; TUMOR ANGIOGENESIS; DECIDUALIZATION; PHOSPHORYLATION; IMPLANTATION; DEGRADATION; ESTRADIOL; SURVIVAL; MODEL;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Heparin has a beneficial effect in the treatment of recurrent miscarriages and positively affects implantation rates in the IVF procedure in women with reproductive disorders not associated with thrombophilia. Several studies have indicated that heparin, by blocking the enzymatic activity of heparanase, may affect the structure and function of the extracellular matrix (ECM) and related growth factors. Disturbances in the remodeling (ECM) are believed to be the potential cause of implantation disorders and recurrent miscarriages. Objectives: The aim of the study was the evaluation, on an in vitro model, of the effect of low molecular weight heparin (LMWH) on the expression of heparanase (HPSE) and, important for successful implantation and invasion of trophoblast, heparan sulfate (HS) - binding growth factors, i.e. heparin-binding epidermal growth factor-like (HB-EGF), vascular endothelial growth factor (VEGF-A), fibroblast growth factor (FGF2) in the endometrium, during the implantation window in women with recurrent miscarriage. Method: Biopsy samples, obtained from 10 patients with two or more unexplained miscarriages, were used to construct a co-culture of glandular epithelial cells and stroma. Endometrium in vitro model was supplemented with steroid hormones and enoxaparin 5ug/ml. Using the qPCR, we assessed relative levels of the HPSE, HB-EGF, VEGF-A and FGF2 transcripts in glandular epithelium and stroma in cell culture. Using ELISA, we measured concentrations of the mentioned above factors in culture medium. Results: A statistically significant increase in the relative level of HPSE, HB-EGF, VEGF-A, FGF2 transcripts in the cells of the glandular epithelium and stroma (p<0.001), as well as their increased concentration in the medium of cultures treated with steroid hormones (p<0.001) were observed. However, we found no effect of LMWH supplementation on the level of the investigated factors. Conclusions: Our results show that the importance of the HPSE hydrolytic activity in the endometrium, during the implantation window, may have a secondary function, and/or that beneficial effects of LMWH in women with impaired reproduction have no significant, direct connection with the, catalyzed by HPSE, reconstruction of the ECM and with release of heparin-binding growth factors.
引用
收藏
页码:908 / 915
页数:8
相关论文
共 50 条
  • [41] Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with anti phospholipid syndrome treated with low molecular weight heparin
    Prakash, A
    Laird, S
    Li, TC
    Ledger, WL
    FERTILITY AND STERILITY, 2006, 85 (01) : 165 - 170
  • [42] Hereditary thrombophilia and low -molecular -weight heparin in women: useful determinants, including thyroid dysfunction, incorporating the management of treatment and outcomes of the entity
    Dugalic, Stefan
    Petronijevic, Milica
    Sengul, Demet
    Detanac, Dzenana A.
    Sengul, Ilker
    Veiga, Eduardo Carvalho de Arruda
    Stanisavljevic, Tamara
    Macura, Maja
    Todorovic, Jovana
    Gojnic, Miroslava
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (02): : 335 - 340
  • [43] Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study
    Keepanasseril, Anish
    Pillai, Ajith Ananthakrishna
    Baghel, Jyoti
    Pande, Swaraj Nandini
    Mondal, Nivedita
    Munuswamy, Hemachandren
    Kundra, Pankaj
    D'Souza, Rohan
    GLOBAL HEART, 2021, 16 (01)
  • [44] Basic-fibroblast-growth-factor-mediated de novo angiogenesis is more effectively suppressed by low-molecular-weight than by high-molecular-weight heparin
    Norrby, K
    Ostergaard, P
    INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL, 1996, 16 (01): : 8 - 15
  • [45] Inhibition of HIV-1 infectivity by low molecular weight heparin - Results of in vitro studies and a pilot clinical trial in patients with advanced AIDS
    Howell, AL
    Taylor, TH
    Miller, JD
    Groveman, DS
    Eccles, EH
    Zacharski, LR
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1996, 26 (02) : 124 - 131
  • [46] Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells
    Takeuchi, Akihiko
    Yamamoto, Yasuhiko
    Munesue, Seiichi
    Harashima, Ai
    Watanabe, Takuo
    Yonekura, Hideto
    Yamamoto, Hiroshi
    Tsuchiya, Hiroyuki
    CANCER SCIENCE, 2013, 104 (06): : 740 - 749
  • [47] Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases
    Cassinelli, Giuliana
    Dal Bo, Laura
    Favini, Enrica
    Cominetti, Denis
    Pozzi, Sabina
    Tortoreto, Monica
    De Cesare, Michelandrea
    Lecis, Daniele
    Scanziani, Eugenio
    Minoli, Lucia
    Naggi, Annamaria
    Vlodaysky, Israel
    Zaffaroni, Nadia
    Lanzi, Cinzia
    CANCER LETTERS, 2018, 415 : 187 - 197
  • [48] Impact of bridging with perioperative low-molecular-weight heparin on cardiac and bleeding outcomes of stented patients undergoing non-cardiac surgery
    Capodanno, Davide
    Musumeci, Giuseppe
    Lettieri, Corrado
    Limbruno, Ugo
    Senni, Michele
    Guagliumi, Giulio
    Valsecchi, Orazio
    Angiolillo, Dominick J.
    Rossini, Roberta
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (02) : 423 - 431
  • [49] Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women
    Mello, G
    Parretti, E
    Fatini, C
    Riviello, C
    Gensini, F
    Marchionni, M
    Scarselli, GF
    Gensini, GF
    Abbate, R
    HYPERTENSION, 2005, 45 (01) : 86 - 91
  • [50] Improved angiogenesis and healing in crush syndrome by fibroblast growth factor-2-containing low-molecular-weight heparin (Fragmin)/protamine nanoparticles
    Takikawa, Makoto
    Nakamura, Shingo
    Ishihara, Masayuki
    Takabayashi, Yuki
    Fujita, Masanori
    Hattori, Hidemi
    Kushibiki, Toshihiro
    Ishihara, Miya
    JOURNAL OF SURGICAL RESEARCH, 2015, 196 (02) : 247 - 257